awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49307383-074AC749-BCC8-41C7-8F18-26C817BD2CB8
Q49307383-074AC749-BCC8-41C7-8F18-26C817BD2CB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49307383-074AC749-BCC8-41C7-8F18-26C817BD2CB8
Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA.
P2860
Q49307383-074AC749-BCC8-41C7-8F18-26C817BD2CB8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49307383-074AC749-BCC8-41C7-8F18-26C817BD2CB8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f11ea6048c0aa3c094a3a17439985492c50b6ad7
P2860
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.